Background A pregnancy loss (miscarriage) is defined as the spontaneous demise of a pregnancy before the fetus reaches viability. The term therefore includes all pregnancy losses (PLs) from the time of conception until 24 weeks of gestation. Polycystic ovary syndrome (PCOS) is a common endocrine system disorder among women in which levels of the sex hormones are disrupted. Hyperhomocysteinemia has been associated with clinical vascular thrombosis, and this could be the cause for early decidual and chorionic vessel damage that might result in disturbed implantation of the conceptus. Objective To determine the plasma homocysteine levels in patients with PCOS having recurrent pregnancy loss (RPL) compared with women with PCOS without RPL. Patients and methods This is a case–control study on 30 women with PCOS with RPL and 30 control women with PCOS without RPL. Plasma homocysteine levels were assessed from February 2019 to February 2020 at Al Zahraa University Hospital. Results There was a significant increase in the mean homocysteine level in the case group (20.14±3.21) compared with controls (9.01±2.24) (P=0.001), with odds ratio=2.193 (confidence interval 0.171–23.294) by homocysteine through cut-off more than 12 mmol/l. Conclusion Risk of RPL in patients with PCOS is increased with hyperhomocysteinemia (P<0.001).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.